Bone tissue undergoes constant turnover supported by stem cells. Recent studies showed that perivascular mesenchymal stem cells (MSCs) contribute to the turnover of long bones. Craniofacial bones are flat bones derived from a different embryonic origin than the long bones. The identity and regulating niche for craniofacial bone MSCs remain unknown. Here, we identify Gli1+ cells within the suture mesenchyme as the major MSC population for craniofacial bones. They are not associated with vasculature, give rise to all craniofacial bones in the adult and are activated during injury repair. Gli1+ cells are typical MSCs in vitro. Ablation of Gli1+ cells leads to craniosynostosis and arrest of skull growth, indicating these cells are an indispensible stem cell population. Twist1 +/− mice with craniosynostosis show reduced Gli1+ MSCs in sutures, suggesting that craniosynostosis may result from diminished suture stem cells. Our study indicates that craniofacial sutures provide a unique niche for MSCs for craniofacial bone homeostasis and repair.
Introduction
Craniofacial bones differ from the long bones. They are flat bones formed mainly through intramembranous rather than endochondral ossification and develop from embryological origins distinct from those of the long bones [1] [2] [3] . Perivascular mesenchymal stem cells (MSCs) have been identified in the bone marrow of the long bones and support their turnover and injury repair [4] [5] [6] [7] . Craniofacial bones contain little bone marrow space and are sheathed by periosteum and endosteum or dura 8, 9 . Although the question of whether there is a specific stem cell population in adult craniofacial bones has remained unanswered, it was generally assumed that these flat bones share the same turnover and injury repair mechanisms as long bones. It has been proposed that the periosteum contains progenitors that support craniofacial bone repair [10] [11] [12] [13] .
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The joints between craniofacial bones are known as sutures and are composed of two osteogenic fronts with suture mesenchyme between them (Supplementary Figure 1) . Most sutures in mice remain patent throughout the animal's lifetime. In humans, cranial sutures normally fuse between 20 and 30 years of age and facial sutures fuse after 50 years of age 14, 15 .
Craniosynostosis is a common congenital disorder characterized by premature cranial suture fusion, which may lead to severe outcomes including increased intracranial pressure, craniofacial dysmorphism, disrupted neurodevelopment, and mental retardation. Craniosynostosis is generally considered a developmental disorder resulting from a disrupted balance of cellular proliferation, differentiation and apoptosis within the suture [15] [16] [17] [18] [19] . Surgical removal of the affected suture followed by re-shaping of the calvarial bones remains the only treatment available for craniosynostosis patients [20] [21] [22] . Although the purpose of the surgery is to form artificial suture-like space between the calvarial bones to allow for brain expansion, the natural suture tissue is treated as surgical waste and routinely discarded during the procedure [23] [24] [25] .
In our current study, using mouse craniofacial bones as a model, we identified Gli1+ cells within the suture mesenchyme as the major stem cell population for adult craniofacial bones. They give rise to the periosteum and dura. They are typical MSCs in vitro but are not associated with vasculature and are regulated by IHH secreted from the committed osteogenic progenitors. Ablation of Gli1+ cells in the adult mouse leads to craniosynostosis, skull growth arrest and osteoporosis. The Gli1+ cell population was diminished in craniosynostosis model Twist1 +/− mutant mice, which suggests that compromised stem cells might be the cause of craniosynostosis. Our finding indicates that a different niche regulates the stem cells of craniofacial bones than that of long bones. Craniosynostosis, a severe congenital disease, might be caused by stem cell population defects.
Results

Gli1+ cells are specifically distributed in the suture mesenchyme of adult craniofacial bones
We hypothesized that Gli1+ cells are MSCs for craniofacial bones, as they are for the incisor mesenchyme 26 . First, we investigated the expression of Gli1 in mouse calvarial bones. At postnatal day 0 (P0), Gli1+ cells are detectable throughout the entire periosteum, dura and suture mesenchyme, but not in the fontanelles or osteocytes (Figure 1a, g ). A similar distribution pattern was detectable at P7 and P14 (Figure 1b -c, h-i). Between P21 and 1 month postnatally, Gli1+ cells are gradually restricted to the suture region (Figure 1d e). At one month of age, Gli1+ cells are only detectable within the suture mesenchyme, mostly in the mid-suture region, but are absent from the periosteum, dura and osteocytes (Figure 1j-l) . Such a suture-specific pattern was also detectable in mice at three months of age and older (Figure 1f ).
We next investigated the Gli1+ cell distribution pattern in other craniofacial sutures. In Gli1-LacZ mice at one month of age, we detected Gli1+ cells in the mesenchyme of most craniofacial sutures, including the coronal (Figure 1m Figure 2m) sutures. Gli1+ cells are mainly present in the mid-suture mesenchyme and are absent from the periosteum, dura and bones abutting the sutures. Interestingly, Gli1+ cells are not detectable in the posterior frontal suture mesenchyme at either P8 or P30. The posterior frontal suture is the only suture in the mouse that fuses around two weeks after birth [27] [28] [29] .
Craniofacial bones contain little bone marrow space compared to long bones. Gli1+ cells are also detectable on the inner surface of some bone marrow spaces (Supplementary Figure  4a) . The number of these bone marrow Gli1+ cells differs by location, but only comprises a minor population in craniofacial bones (Supplementary Figure 4b) .
To investigate the differentiation status of suture Gli1+ cells, we evaluated the expression of various osteogenic differentiation markers in the calvarial bones of one-month-old mice. All the markers we tested, including ALPase, Sp7, Runx2 and osteocalcin, are strongly expressed in the periosteum and the dura, but are absent from the majority of the suture mesenchyme (Figure 1q-t) . Within the suture, Sp7 and Runx2 are expressed in a few cells within the osteogenic fronts, which are thin layers of cells immediately lining the bony surface (Figure 1r ', t'). Co-staining indicates Gli1+ cells are located near, but not within, the osteogenic fronts (Supplementary Figure 2n) Gli1+ cells in the suture mesenchyme give rise to osteogenic fronts, periosteum and dura
To test whether Gli1+ cells in the suture mesenchyme are stem cells, we performed lineage tracing analysis. Gli1-Cre ERT2 ;R26ZsGreen flox or Gli1-Cre ERT2 ;R26Tdtomato flox mice (Gli1-CE) were induced with tamoxifen at 1 month of age. Five days after induction, fluorescently labeled cells were detectable exclusively in the mid-suture mesenchyme of the calvaria (Figure 2a Figure 3n) , periosteum, dura or osteocytes of craniofacial bones. One month later, we detected fluorescently labeled cells in the entire suture mesenchyme including the osteogenic fronts ( Supplementary Figure 3n' , o'), part of the periosteum, dura and a few osteocytes next to the osteogenic fronts of calvarial bones (Figure 2b ). Examination of other craniofacial sutures including the sutures in the basal skull region and facial region indicated that significant numbers of cells in the periosteum and bones were already strongly labeled with fluorescence one month after induction (Supplementary Figure 3a' -m'). The presence of Gli1+ cells in these structures can be attributed to both the postnatal growth of the skull vault and the postnatal turnover of craniofacial bones. The turnover rates of different craniofacial bones vary significantly and calvarial bones turn over much slower than other craniofacial bones.
Two months after induction, the entire suture mesenchyme, periosteum and dura as well as parts of the calvarial bones were strongly labeled (Figure 2c) . Most of the labeled calvarial osteocytes were located either next to the suture or peripherally, indicating that new bone deposits mostly at the osteogenic front region and external surface of the calvarial bones. Eight months after induction, the entire calvaria including the suture mesenchyme, periosteum, dura and almost every osteocyte were strongly labeled, suggesting a complete turnover of calvarial bone within this time period (Figure 2d ).
Gli1+ cells in the bone marrow also give rise to osteocytes immediately surrounding the bone marrow space, but not to blood cells (Supplementary Figure 4c-d) . Their contribution to craniofacial bones is limited due to the small percentage of Gli1+ cells in the bone marrow space.
Gli1+ cells contribute to injury repair and transplant growth
Gli1+ cells in the suture mesenchyme normally do not undergo active division. However, within 24 hours after an injury, they can be rapidly activated into proliferation (Figure 3a-b) . To investigate the contribution of Gli1+ cells to injury repair, we induced Gli1-CE mice with tamoxifen at one month of age and made an injury to the calvarial bone. Two weeks after injury, most of the cells within the injured region were strongly labeled, indicating their derivation from Gli1+ cells (Figure 3c ). One month after injury, the periosteum, dura and many osteocytes in the repair region were strongly labeled, indicating Gli1+ cells contribute to post-injury repair of the calvarial bone (Figure 3d ).
Previously, it was proposed that progenitor cells supporting craniofacial bone repair mainly reside in the periosteum. Our lineage tracing analysis indicated that, instead, the suture mesenchyme gives rise to the periosteum and dura during natural turnover. To confirm this relationship, we induced Gli1-CE mice at one month of age. After removing the periosteum and dura, we transplanted a piece of calvarial bone containing the sagittal suture into nude mice.
Only the suture mesenchyme was labeled in samples collected 72 hours after transplantation (Figure 3e ). One week after transplantation, newly generated, fluorescently labeled periosteum and dura were detectable on the surfaces of the transplants (Figure 3f ). One month after transplantation, the suture transplants merged with the host bone. A significant number of cells within the periosteum, dura and bone (osteocytes) of the transplant were strongly labeled, indicating their derivation from the Gli1+ cells within the suture mesenchyme (Figure 3g ). Calvarial bones not containing any suture taken from the same donor mice were also transplanted as controls (Figure 3h ). Although Gli1+ cells in the bone marrow space survived one month after transplantation, they failed to generate new periosteum, dura or osteocytes. Therefore, bone marrow Gli1+ cells are either incapable or insufficient to support efficient repair or regeneration.
To evaluate the regeneration ability of suture tissue and specifically to compare it with the periosteum, we transplanted calvarial bones with or without suture from CMV-EGFP mice of one month of age into nude mice. The suture transplants grew rapidly and doubled their surface area within one month, whereas the control calvarial bone transplants without sutures failed to grow even though they contained intact periosteum and dura (Figure 3i-j) . This result indicates the suture tissue possesses regenerative capacity but periosteum and dura do not, consistent with a previous suture transplantation study 30 .
Gli1+ cells are typical MSCs in vitro
The current definition of MSCs is based upon in vitro assays. Therefore, we evaluated Gli1+ cells in accordance with these standards. Immunohistochemical staining indicated that the majority of Gli1+ cells in the suture mesenchyme do not express MSC markers including CD90, CD73, CD44, Sca1, and CD146 ( Previous studies have proposed that MSCs in the long bone are regulated by a perivascular niche 4 . We therefore set out to test whether Gli1+ cells in the suture are regulated by the same mechanism. In fact, we found that Gli1+ cells in the suture mesenchyme mainly reside around the midline of the structure and do not show a particular affinity for the vasculature (Figure 5a ). After induction, Shh-Cre ERT2 ;R26Tdtomato flox mice do not show any signal in the suture region (Figure 5b ), indicating the absence of SHH from the suture mesenchyme, consistent with a previous study 32 To investigate the function of Hedgehog signaling in regulating suture MSCs, we generated Gli1-Cre ERT2 ;Smoothened flox/flox mice (Smo ICKO) and induced them at one month age. Blockage of the Hh pathway had no obvious impact on suture patency in these mice ( Figure  5g -l). Gli1+ cells could still give rise to periosteum, dura and osteocytes (Supplementary Figure 5p) . However, all the craniofacial bones exhibited severe osteoporosis and reduced bone volume eight months after induction (Figure 5g -l). We also examined the continuously growing incisors in Smo ICKO mice. We found that significant phenotypes appeared much sooner after induction in the incisors. Although the incisors continued growing, they showed significantly reduced odontogenesis and amelogenesis, disrupted odontoblast organization and severe periodontal ligament defects ( Supplementary Figure 5a-l) . Proliferation analysis indicated that loss of hedgehog signaling had no significant effects on the ratio of proliferating cells in either the incisor or sagittal suture (Supplementary Figure 5m-n) . No apoptotic cells were detectable in the incisor or sagittal suture of control or Smo ICKO mice (Supplementary Figure 5o) . To investigate the effects of hedgehog signaling, we harvested suture mesenchymal cells from one-month-old mice and treated them with IHH or hedgehog inhibitor GDC0449. IHH treatment (500ng/ml) 33 significantly up-regulated Gli1 activity, whereas GDC0449 (10μM) 34 significantly down-regulated Gli1 activity ( Supplementary  Figure 5q-s) . Neither treatment had a significant effect on proliferation or apoptosis (Supplementary Figure 5t) . Three weeks after treatment, osteogenic activity was increased in IHH-treated cells and decreased in GDC0449-treated cells (Supplementary Figure 5u-w) . Real-time PCR also confirmed the opposing effects of IHH and GDC0449 on regulating the osteogenic differentiation ability of suture MSCs (Supplementary Figure 5x) . These results indicate that Hedgehog signaling is important for regulating the differentiation of Gli1+ MSCs but not for their maintenance.
Gli1+ cell ablation leads to craniosynostosis, skull growth arrest, osteoporosis and compromised injury repair
To investigate whether Gli1+ stem cells are indispensable for homeostasis and injury repair, we generated Gli1-Cre ERT2 ;DTA flox/flox mice (DTA) and induced them with tamoxifen at one month of age. Theoretically, induction should cause ablation of all Gli1+ cells. We discovered that some Gli1-expressing cells survived the ablation, indicating that the DTA model we generated was not entirely efficient (Supplementary Figure 5z) . However, even this incomplete Gli1+ cell ablation led to striking craniofacial phenotypes. One month after induction, most sutures remain patent except the coronal and frontal-premaxilla sutures, suggesting these two sutures are more sensitive to Gli1+ cell ablation (Figure 6b ). Two months after induction, the general body size of the DTA mice was significantly smaller than that of controls of the same age and was comparable to one-month-old control mice, indicating the arrest of body growth after the ablation (Supplementary Figure 5y) . In addition, all the craniofacial sutures had fused (Figure 6c-g ). The anterior-posterior length and the width of the skull of the DTA mice were reduced by ~20% and 15%, respectively (Figure 6r ). All the craniofacial bones exhibited severe osteoporosis (Figure 6h-m) . Quantitative analysis of the volume of the maxillary bone, palatal bone and basosphenoid bone showed that all were reduced by over 40% (Figure 6r ). HE staining confirmed the disappearance of the sagittal suture and coronal suture as well as the presence of porous bone structure (Figure 6n-q) .
To evaluate the impact of Gli1+ cell ablation on injury repair, we injured the calvarial bone of DTA mutants and controls one month after their induction. Although inspection of the control samples revealed that they had healed completely after one month, the injury sites in the DTA mutant calvarial bones remained open, indicating a compromised healing process (Figure 6s-t) .
The stem cell population is diminished in the sutures of Twist1 +/− mice with craniosynostosis Our identification of Gli1+ stem cells in the craniofacial sutures and the craniosynostosis phenotype observed after Gli1+ cell ablation suggest that premature loss of stem cells from the suture causes the premature suture fusion observed in craniosynostosis.
To test this hypothesis, we generated Twist1 +/− ;Gli1-LacZ +/− mice. Twist1 +/− is a widely accepted synostosis mouse model and the corresponding mutation in humans is linked to Saethre-Chotzen syndrome, which is the most common craniosynostosis disorder [35] [36] [37] [38] . Whole-mount LacZ staining of mice at one month of age indicated that the number of Gli1+ cells was significantly reduced (Figure 7 a-f) . Gli1+ cells were not detectable in regions of fused coronal suture (Figure 7f-b' ). Even in sutures of Twist1 +/− mutants that remain patent, such as the coronal, lambdoid and sagittal sutures, the number of Gli1+ cells was reduced, and the reduction was more severe in the synostosed sutures (Figure 7d-g ).
Next, we isolated suture mesenchymal cells from Twist1 +/− mutants and littermate control calvarial bones. In vitro cultures indicated that both clone formation efficiency and clone size of Twist1 +/− suture mesenchymal cells were reduced by over 50% (Figure 7h ). Synostosis occurs between P9 and P13 in Twist1 +/− mice 37, [39] [40] [41] . To investigate whether loss of Gli1+ cells occurs prior to suture closure, we examined Gli1 expression at P1, P7 and P14. Whole-mount LacZ staining indicated that Gli1+ cells in Twist1 +/− mice at P1 did not differ significantly from controls in their number or distribution pattern (Figure 7i, l) . At P7 and P14, Gli1+ cells were significantly reduced in all sutures of Twist1 +/− mice (Figure 7j -k, m-n). To investigate the reduction in Gli1+ cells, we performed proliferation and apoptosis assays. EdU incorporation assays in P5 pups indicated that the number of proliferating cells in the sutures of Twist1 +/− mice was reduced by nearly 50% (Figure 7o, q) . At P5, discontinuous apoptotic cell foci were detectable in the coronal and lambdoid sutures of Twist1 +/− mice, whereas no apoptotic cells were detectable in the sagittal sutures ( Figure  8p) 
Discussion
Our study shows that Gli1+ cells in the suture mesenchyme are stem cells for craniofacial bones. They give rise to the osteogenic front, periosteum, dura and craniofacial bones (Supplementary figure 6a) . The Gli1+ population provides an indispensable stem cell source supporting craniofacial bone turnover and injury repair in the adult. These Gli1+ cells can be considered osteogenic stem cells because they largely or perhaps exclusively give rise to bone tissue; craniofacial bones contain few chondrocytes except in the basal skull and nasal septum. The periosteum and dura are mainly comprised of committed osteogenic progenitors, as evidenced by their high expression of differentiation markers, and these tissues derive from the suture (Supplementary figure 6a) .
Gli1 is specifically expressed within the suture mesenchyme but not in hematopoietic cells or endothelium 26 . Gli1+ cells in the suture mesenchyme are not perivascular, as tendon stem cells are 42, 43 . IHH secreted from progeny cells in the osteogenic front regulates the differentiation of Gli1+ MSCs within the suture (Supplementary figure 6 b) . 26, 44, 45 . Craniofacial bones contain limited bone marrow space and the Gli1+ cells within the marrow also contribute to new bone formation. Their contribution to craniofacial bones is less significant than that of the suture MSCs based on our transplantation experiments and their small population size.
Ablation of Gli1+ cells leads to fusion of all craniofacial sutures in adult mice. The fusion might be due to the loss of a constant stem cell supply that is needed to produce sufficient undifferentiated mesenchymal cells to keep the suture patent. Combining the craniosynostosis phenotypes after Gli1+ cell ablation with the reduced Gli1+ cell numbers observed in Twist1 +/− sutures, we propose a mechanism for explaining craniosynostosis, namely that premature loss of MSCs from a craniofacial suture can contribute to craniosynostosis. This concept of the disease will have a profound impact on our approach to diagnosis, prevention and treatment of craniosynostosis. Twist1 is specifically expressed in the suture mesenchyme after E16 41 . Twist1 +/− mice exhibit increased apoptosis and reduced proliferation within the suture mesenchyme 46, 47 , likely resulting in the reduced Gli1+ cells that we reported. It appears that there is a threshold number of suture stem cells required for maintaining suture patency. This may help to explain the often-asymmetrical nature of craniosynostosis.
In summary, we have identified Gli1+ cells within the suture mesenchyme as an indispensable MSC population supporting craniofacial bone turnover and injury healing. These stem cells are not associated with vasculature and are regulated by IHH secreted from the osteogenic front. Gli1+ cells in the suture mesenchyme do not express conventional MSC markers in vivo; their derivatives in vitro, however, express all these markers and behave like typical MSCs 26, [48] [49] [50] . Collectively, our study will have a profound impact on the understanding of craniofacial bones as well as the pathogenesis of craniosynostosis and other craniofacial disorders.
Methods
Histology
Samples were dissected under a stereomicroscope (Leica L2) and fixed in 4% paraformaldehyde overnight at room temperature, then decalcified in 20% EDTA for 14 days. Decalcified samples were dehydrated in 60% sucrose/PBS solution overnight at room temperature. Samples were embedded in an OCT compound (TissuTek, Sakura) under a stereomicroscope and transferred onto dry ice to solidify. Embedded samples were cryosectioned at 16 μm thickness using a cryostat (Leica CM1850). Images were captured using a fluorescence microscope (Leica DMI 3000B) with filter settings for DAPI/FITC/ TRITC and merged with Adobe Photoshop CS6. Confocal images were acquired using Leica LAS AF software (Leica) with lasers and corresponding band-pass filters for DAPI (Ex. 405 nm, BP410-490), GFP (Ex. 488 nm, BP450-550), tdTomato (Ex. 543 nm, BP550-595) and Alexa633 (Ex. 633 nm, LP650). Adobe Photoshop software was used to capture and align images. Representative images from at least three independent samples or experiments are shown in the figures (see Reproducibility of experiments).
Tamoxifen administration
Tamoxifen (Sigma T5648) was suspended in corn oil (Sigma C8267) at 20 mg/ml and injected intraperitoneally (i.p.) at a dosage of 10 mg daily for 4 days.
EdU incorporation and TUNEL assays
EdU (200 mg/kg) (Life Technology A10044) was injected i.p. 2 hours prior to sacrifice. The specimens were fixed overnight in 4% PFA and decalcified in 20% EDTA for 2 weeks. Tissues were embedded in OCT compound (Sakura Tissue-Teck 4583), frozen, and sectioned at 12-18 μm thickness. EdU+ cells were detected with the Click-iT® EdU Alexa Fluor® 488 Imaging Kit (Invitrogen C10337) according to the recommended protocol. Apoptotic cells were detected with the In Situ Cell Death Detection Kit (Roche Life Science 11684795910) according to the recommended protocol. For quantification of EdU+ or TUNEL+ cells, we counted the number of nuclei marked by staining in each section.
Suture transplantation
Our surgical protocol was adapted from a previous study 51 . After sacrificing donor mice, a section of sagittal suture 2mm in length was dissected together with ~0.5mm of abutting parietal bone on each side. The periosteum and dura were either preserved or carefully removed with a scalpel depending on the experimental design. Each transplant was imaged under a microscope before transplantation to measure its initial size. Nude mice were used as the recipient mice. Under general anesthesia, a midline sagittal skin incision was made and a scalp flap was elevated to reveal the calvaria. The periosteum was retracted over the left and right parietal bones from the mid-sagittal incision to expose the underlying bone. A 4mm 2 defect was made in the center of the left or right parietal bone of the host using a hand-held drill (NSK Z500). Extreme care was taken not to damage the underlying dura. Donor transplants were placed over the recipient calvarial window with the dura side facing the brain. No additional fixation was necessary. The host skin was sutured using 4.0 nylon stitches.
Suture and calvarial bone injury assays
In the suture injury assay, a midline sagittal incision was made under general anesthesia and the scalp was revealed to expose the sagittal suture. A 25 gauge needle was used to scratch the sagittal suture surface. The scalp was then sutured together with 4.0 nylon stitches. In the calvarial bone injury assay, the scalp was cut and elevated to expose the parietal bones. A dental round burr was used to drill a hole of ~1mm diameter 2mm away from the sagittal suture in the parietal bone. The scalp was then sutured with silk stitches.
Statistical analysis
SPSS software version 13.0 was used for statistical analysis. Significance was assessed using independent two-tailed Student's t-tests or analysis of variance (ANOVA). A p value less than 0.05 was considered significant. No statistical method was used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment.
Immunohistochemical staining
The following antibodies were used in our study: β-Gal (Novus NP600-305, 1:50), Gli1 (Novus Biological NBP1-78259, 1:25), CD44 (BD Bioscience 561859, clone IM7, 1:100), CD73 (BD Bioscience 561545 clone TY/23, 1:100), CD 105 (BD Bioscience 561443, clone266, 1:100), CD146 (BD Bioscience 562229, cloneME-9F1, 1:100), Sca1 (BD Bioscience 561077, clone E13-161.7, 1:100), Sp7 (Abcam ab22552, 1:100), Runx2 (Abcam ab61753, 1:100), Osteocalcin (Abcam ab93876), perilipin (Abcam ab3526, 1:100). Staining was performed according to standard procedures. The data from immunohistochemical staining experiments were representatives of 3 independent experiments (see Reproducibility of experiments).
Real-time PCR
The mRNA levels of ALPase, Runx2, Sp7 and Osteocalcin were analyzed by real-time quantitative RT-PCR. Cells were collected from the culture dishes and total RNA was extracted using the RNeasy Mini Kit (Qiagen 74104). 1 μg total RNA was reversetranscribed with oligo-dT primers into cDNAs using SuperScript™ III First-Strand (Invitrogen #18080-051). Real-time PCR was performed using a SYBR super mix kit (BioRad #170-8880) as reported previously 52 . For thermal cycling, a CFX96 Real-Time System (Bio-Rad iCycler) was used at 95°C for 10min then 40 cycles of 95°C for 10 seconds and 55°C for 30 seconds. The relative amount of each mRNA transcript was calculated based on a standard curve of cycle thresholds and normalized to β-actin expression as the internal control. Real-time PCR was performed in triplicate for each sample. All experiments were repeated three times. The primers are as follows: mouse β-actin, 5′-GCAAGTGCTTCTAGGCGGAC-3′ and 5′-AAGAAAGGGTGTAAAACGCAGC-3′; mouse ALPase, 5'-GCTGATCATTCCCACGTTTT-3' and 5'-CTGGGCCTGGTAGTTGTTGT-3'; mouse Runx2, 5'-CCCAGCCACCTTTACCTACA-3' and 5'-TATGGAGTGCTGCTGGTCTG-3'; mouse Sp7, 5'-AGTTCACCTGCCTGCTCTGT-3' and 5'-GGAGCTGGAGACCTTCCTCT-3'; mouse Osteocalcin, 5'-AAGCAGGAGGGCAATAAGGT-3' and 5'-ACTTGCAGGGCAGAGAGAGA-3'.
X-gal staining
Samples from mice were fixed in 0.2% glutaraldehyde overnight and then decalcified with 20% EDTA for 2 weeks. Frozen sections were cut of 12 μm thickness. Sections or cultured cells were stained with X-gal (C 14 H 15 BrClNO 6 , USB) overnight at 37°C according to standard procedure.
Suture mesenchymal cell mass culture, clonal culture and multipotential differentiation
Our suture mesenchymal cell culture procedure was adopted from previous studies 31, 53 . After removing the periosteum and dura, the sagittal suture was excised along with ~0.5mm of abutting parietal bone on each side. The suture tissue was minced into tiny pieces and the tissue blocks were transferred into a T25 culture flask (Corning CLS430639) and incubated with αMEM+20% FBS (Invitrogen 10437-085) at 37°C in regular atmospheric conditions. For clonal culture of suture mesenchymal cells, 1000 cells from the sagittal suture mesenchyme were plated in a T75 culture flask (Corning CLS430641) coated with fibronectin (Invitrogen 33010-018) and incubated with αMEM+20% FBS (Invitrogen 10437-085) at 37°C under hypoxic conditions (5% O 2 , 5% CO 2 , balanced with Nitrogen). Clones could be detected ~10 days after plating. Single clones were circled with a cloning ring and digested with TrypLE (Invitrogen 12605). Cells were divided and plated into three wells in a fibronectin-coated 24-well culture plate (Corning CLS3527) and cultured under hypoxic conditions until confluence. Osteogenic, adipogenic or chondrogenic differentiation was then performed as previously described 54 .
Flow cytometry analysis
Cultured suture mesenchymal cells of p0 or p1 were dissociated into single cells by treating the cells with 0.25% trypsin (Life Technology, 25200-056) for 40 min at 37°C and vigorous pipetting. Cells were then filtered with a 35 μm cell strainer (BD Falcon, 352235) to remove the residual cell mass. Cell suspensions were stained with FITC-conjugated antibodies for 30 min at 4°C followed by extensive washing with PBS. The following antibodies were used at 1:30 dilution: CD34 (BD Bioscience 560238, clone RAM34), CD44 (BD Bioscience 561859, clone IM7), CD45 (BD Bioscience 553080, clone 30-F11), CD73 (BD Bioscience 561545 clone TY/23), CD105 (BD Bioscience 561443, clone266), CD146 (BD Bioscience 562229, cloneME-9F1), Sca1 (BD Bioscience 561077, clone E13-161.7), IgG1 (BD Bioscience 554679, clone MOPC-21), IgG2a (BD Bioscience 553929, clone R35-95) and IgG2b (BD Bioscience 557726, clone A95-1) isotype control of IgG. Flow cytometry analysis was performed according to standard procedures as previously described 54 . All samples were analyzed with FACS calibur (BD Bioscience).
Animal information
We obtained the following mouse strains from the Jackson Laboratory: Shh-Cre ERT2 (JAX# 005623) 55 , Gli1-LacZ (JAX#008211) 56 , Nude (JAX#007850), Gli1-Cre ERT2 (JAX#007913) 57 , ROSA26 LoxP-STOP-LoxP-ZsGreen1 (JAX#007906) 58 , ROSA26 LoxP-STOP-LoxP-DTA (JAX#009669) 59 , Smo flox/flox (JAX#004526) 60 , ROSA26 LoxP-STOP-LoxP-Tdtomato (JAX#007905) 58 , ROSA26 LoxP-STOP-LoxPLacZ (JAX#003474) 61 and CAG-EGFP (JAX#003516) 62 . Ihh-LacZ mice were kindly provided by Andrew McMahon. Mouse experiments were approved by the University of Southern California Institutional Animal Care and Use Committee and performed following the regulations for animal experiments at University of Southern California. All mice were housed in a pathogen-free condition and analyzed in a mixed background. Mice were identified by ear tags. Tail biopsies of mice were lysed by incubating the tail sample at 55°C overnight in DirectPCR tail solution (Viagen 102-T) followed by 85°C heat inactivation for 30 minutes and used for PCR-based genotyping (GoTaq Green Master Mix, Promega, and C1000 Touch Cycler, Bio-rad). Mice were euthanized by carbon dioxide or decapitation. All mice were used for analysis regardless of sex.
For the experiments in Figure 1a -p, male Gli1-LacZ mice were mated to female CD1 mice (>8 weeks old, Jackson Lab) and vaginal plugs were checked the next morning. Newborn pups were counted as P0. Mice at indicated ages were collected and genotyped.
For experiments in Figure 2a -i, Gli1-Cre ERT2 ;ROSA26 LoxP-STOP-LoxP-ZsGreen1 mice of mixed background were injected with tamoxifen at one month of age. Samples were collected at indicated time points after induction.
For the experiments in Figure 3a Figures 1a-p, 2a-i,3e-h, 4h-m, 5g-l, 7i-n 
Reproducibility of experiments
